AR101673A1 - Composición para el tratamiento de neuropatías y del dolor neuropático - Google Patents
Composición para el tratamiento de neuropatías y del dolor neuropáticoInfo
- Publication number
- AR101673A1 AR101673A1 ARP150102653A ARP150102653A AR101673A1 AR 101673 A1 AR101673 A1 AR 101673A1 AR P150102653 A ARP150102653 A AR P150102653A AR P150102653 A ARP150102653 A AR P150102653A AR 101673 A1 AR101673 A1 AR 101673A1
- Authority
- AR
- Argentina
- Prior art keywords
- vitamin
- neuropathies
- treatment
- neuropathic pain
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Composición para el tratamiento de neuropatías y/o del dolor neuropático. Composición farmacéutica o integrador alimenticio para el tratamiento de neuropatías y/o del dolor neuropático que comprende, como principios activos, la combinación de curcumina, N-acetil-L-carnitina y ácido a-lipoico. Reivindicación 9: Composición farmacéutica o integrador alimenticio según una cualquier de las reivindicaciones 1 a 8, que comprende además una o más vitaminas seleccionadas en el grupo que consiste en vitamina C, vitamina E, vitamina B1, vitamina B2, vitamina B6 y vitamina B12.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITTO20140670 | 2014-08-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR101673A1 true AR101673A1 (es) | 2017-01-04 |
Family
ID=51753396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP150102653A AR101673A1 (es) | 2014-08-19 | 2015-08-18 | Composición para el tratamiento de neuropatías y del dolor neuropático |
Country Status (9)
Country | Link |
---|---|
US (2) | US9980940B2 (es) |
EP (1) | EP3182965B1 (es) |
AR (1) | AR101673A1 (es) |
ES (1) | ES2735374T3 (es) |
IL (1) | IL250594B (es) |
PL (1) | PL3182965T3 (es) |
TR (1) | TR201909773T4 (es) |
UY (1) | UY36273A (es) |
WO (1) | WO2016027224A1 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3277273B1 (en) * | 2015-03-31 | 2020-02-26 | Kolinpharma S.p.A. | A composition for the treatment of neuropathies and/or neuropathic pain |
IT201700111261A1 (it) * | 2017-10-04 | 2019-04-04 | Neilos S R L | Composizione per il trattamento delle neuropatie metaboliche e meccaniche |
WO2023086113A1 (en) * | 2021-11-11 | 2023-05-19 | Muhammed Majeed | Compositions for the management of demyelinating disorders |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005032478A2 (en) | 2003-10-01 | 2005-04-14 | Yasoo Health, Inc. | Treatment for diabetic microvascular and macrovascular complications |
US8247435B2 (en) * | 2009-02-19 | 2012-08-21 | Thornthwaite Jerry T | Formulations for treating human and animal diseases |
-
2015
- 2015-08-18 EP EP15771253.0A patent/EP3182965B1/en active Active
- 2015-08-18 UY UY0001036273A patent/UY36273A/es not_active Application Discontinuation
- 2015-08-18 TR TR2019/09773T patent/TR201909773T4/tr unknown
- 2015-08-18 ES ES15771253T patent/ES2735374T3/es active Active
- 2015-08-18 PL PL15771253T patent/PL3182965T3/pl unknown
- 2015-08-18 WO PCT/IB2015/056266 patent/WO2016027224A1/en active Application Filing
- 2015-08-18 US US15/503,080 patent/US9980940B2/en active Active
- 2015-08-18 AR ARP150102653A patent/AR101673A1/es unknown
-
2017
- 2017-02-14 IL IL250594A patent/IL250594B/en active IP Right Grant
-
2018
- 2018-04-27 US US15/964,371 patent/US20180243262A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US20180243262A1 (en) | 2018-08-30 |
UY36273A (es) | 2016-04-01 |
WO2016027224A1 (en) | 2016-02-25 |
EP3182965A1 (en) | 2017-06-28 |
TR201909773T4 (tr) | 2019-07-22 |
ES2735374T3 (es) | 2019-12-18 |
US20170224656A1 (en) | 2017-08-10 |
PL3182965T3 (pl) | 2019-11-29 |
US9980940B2 (en) | 2018-05-29 |
EP3182965B1 (en) | 2019-04-17 |
IL250594B (en) | 2019-09-26 |
IL250594A0 (en) | 2017-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2018000706A1 (es) | Derivados de pirazolopirimidina como inhibidores btk para el tratamiento del cancer. | |
BR112018003745A2 (pt) | composições que compreendem um composto de urolitina | |
DOP2016000253A (es) | Nuevos compuestos | |
CL2015002677A1 (es) | Composiciones que comprenden selenio y uso de las mismas para el tratamiento y prevención de enfermedades o condiciones asociadas con la disfunción mitocondrial. | |
CL2019001194A1 (es) | Extracto de una composición herbal como agente antimicrobiano y/o antibiopelícula. | |
BR112017003346B8 (pt) | Derivados de pirazolopiridina, seus usos, e composição farmacêutica | |
BR112018003780A2 (pt) | composições que compreendem um composto de urolitina | |
MX2017004772A (es) | Composiciones y métodos para la administración fisiológica utilizando cannabidiol. | |
GT201700280A (es) | Formulación sólida oral que contiene irinotecán y método de preparación de la misma | |
DOP2016000251A (es) | Inhibidores de las vías de señalización de wnt | |
CO2018010937A2 (es) | Sistemas de formulación para glicolípidos antimicrobianos | |
BR112017022523A2 (pt) | ?formulação para cápsulas de gel, cápsula de gel, e, processo?. | |
AR101673A1 (es) | Composición para el tratamiento de neuropatías y del dolor neuropático | |
FR3016289B1 (fr) | Extrait vegetal comprenant des sucrose-esters en tant que principe actif et son utilisation dans une composition cosmetique, dermatologique ou nutraceutique | |
CL2017001472A1 (es) | Composiciones y métodos que comprenden triglicéridos de cadena media para el tratamiento de la epilepsia. | |
AR098742A1 (es) | Composición alimenticia realzadora de la palatabilidad para alimento para mascotas y método de preparación | |
CR20190007A (es) | Composiciones farmacéuticas sólidas y formas de dosificación que comprenden aceites. | |
UY36598A (es) | Composición para el tratamiento de neuropatías y/o dolor neuropático | |
ECSP21027009A (es) | Derivados de 4-pirazin-2-ilmetil-morfolina y su uso como medicamento | |
BR112017014295A2 (pt) | composição farmacêutica. | |
MA39009A (fr) | Compositions pharmaceutiques comprenant un agent actif | |
AR105413A1 (es) | Composición farmacéutica para el tratamiento de enfermedades gastrointestinales | |
AR096540A1 (es) | Producto regulador de la salubridad en las plantas, procedimiento de obtención y uso del mismo | |
GT201400115A (es) | Combinación farmacéutica antineurítica y composición | |
ES2656666T3 (es) | Alimento para fines médicos especiales o formulación de suplemento alimenticio para tratar trastornos auditivos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |